Independent Pharmacy for Sale — Louisiana

The pharmacy is contracted with all major insurance. Their current payer mix is 40% Medicaid, 20% Commercial Insurance, 15% Medicare, 15% Cash, and 10% other. The pharmacy has more than doubled its gross revenue over the past two years, generating $3,156,664 in 2022 and $7,317,427 in 2023 with an adjusted EBITDA of $1,166,796. In 2024, they anticipate reaching $12 million in gross revenue with an adjusted EBITDA margin in the 15% range.